Logo for GRI Bio Inc

GRI Bio Investor Relations Material

Latest events

Logo for GRI Bio

Q1 2025

15 May, 2025
Logo for GRI Bio

Q4 2024

14 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from GRI Bio Inc

Access all reports
GRI Bio Inc. is a biotechnology company focused on developing therapies for inflammatory, fibrotic, and autoimmune diseases. The company specializes in modulating natural killer T (NKT) cells to target immune system dysregulation. Its research and development efforts aim to advance novel small-molecule drug candidates for conditions with high unmet medical needs. The company is headquartered in La Jolla, California, and its shares are listed on the NASDAQ.